Former Executive Vice President, Chief Financial Officer · ACADIA PHARMACEUTICALS INC (ACAD)

Todd Young

A named executive officer of ACADIA PHARMACEUTICALS in every fiscal year CompBrief holds from FY2016 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$1,386,333

Salary $350,568Stock awards $99,761

FY2017: $3,301,619

5th of 5 named executive officers at Acadia Pharmaceuticals by FY2018 total.

5 named officers on file for ACADIA PHARMACEUTICALS, FY2018

Todd Young’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 5 equity grants, each cited to its filing
  • ACAD’s disclosed peer group of 23 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ACADIA PHARMACEUTICALS’s whole pay program stands against its peers

  • ACADIA PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ACAD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2019 (DEF 14A).

Free

Get Todd Young’s full pay file as a PDF — free

More than this page: up to 10 years of Todd’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Todd Young compensation by year

ACADIA PHARMACEUTICALS Summary Compensation Table · all 3 fiscal years held
In US dollars, as ACADIA PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018
Salary$147,462$409,542$350,568
Bonus$61,381$0$0
Stock awards$0$0$99,761
Option awards$4,287,440$2,675,273$973,878
Non-equity incentive$0$201,572$0
All other$200,260$15,232$61,887
Total$4,696,543$3,301,619$1,386,333

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ACADIA PHARMACEUTICALS INC DEF 14A filed April 30, 2019, accession 0001193125-19-129723, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ACADIA PHARMACEUTICALS INC filed document, accession 0001193125-19-129723. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2019.

$4.7M
$3.3M
$1.4M
FY16
FY17
FY18
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

ACADIA PHARMACEUTICALS’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Stephen DavisChief Executive Officer$6,508,032
Srdjan StankovicPresident$5,678,381
Michael YangFormer Executive Vice President, Chief Commercial Officer$3,182,910
Austin KimExecutive Vice President, General Counsel, and Secretary$2,126,212
Todd Young · this pageFormer Executive Vice President, Chief Financial Officer$1,386,333

The full ACADIA PHARMACEUTICALS compensation record

free company brief

This page is one person within ACADIA PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ACADIA PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Todd Young's compensation dossier · One-time report. No refunds.